drugset / Trial / NCT01880619

Comparison of Tamsulosin and Solifenacin in Treatment of Ureteral Stent Symptoms

NCT01880619

Phase 4 Completed 131 enrolled Mansoura University
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will be conducted to compare the effectiveness of alpha blocker (Tamsulosin) and Anticholinergic (Solifenacin) in relieving lower urinary tract symptoms caused DJ ureteral stents.

Timeline

Start
2013-01
Primary completion
2014-05
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Solifenacin Small molecule 5 mg
Comparator Tamsulosin Other / unclassified 0.4 mg

Indications

No indication recorded.